<DOC>
	<DOCNO>NCT01306799</DOCNO>
	<brief_summary>Patients severe acid reflux and/or Barrett 's esophagus recommend take Proton pump inhibitor ( PPIs ) indefinitely prevent complication stricture development type esophageal cancer . Recently , study suggest take medication long-term basis may affect bone . Therefore , important learn whether medication may lead accelerate bone loss effective preventive measure develop patient require medication acid-related condition . Several study report patient receive PPIs many year may increase risk hip fracture . However , unclear whether PPIs cause reduce bone density whether increase risk fracture nothing PPIs patient require PPIs illness cause increased fracture . The purpose study learn bone structure bone mass change long-term PPI use .</brief_summary>
	<brief_title>To Learn How Bone Structure Bone Mass Change After Long-term PPI Use</brief_title>
	<detailed_description>Proton pump inhibitor ( PPIs ) among widely use medication . It become increasingly common patient take potent acid suppressant long-term continuous basis erosive esophagitis , Barrett 's esophagus protection nonsteroidal anti-inflammatory drug-related gastropathy . PPI therapy lead elevate serum gastrin level may impair absorption calcium food-bound vitamin B12 . PPI-induced hypergastrinemia direct trophic effect parathyroid gland , lead parathyroid hyperplasia , increase parathyroid hormone secretion bone loss . Furthermore , calcium malabsorption vitamin B12 deficiency associate reduce bone mineral density ( BMD ) increase osteoporotic fracture risk . Consistent data , recent study reveal positive association PPI therapy risk osteoporotic fracture . Peripheral quantitative compute tomography ( pQCT ) provide three-dimensional structural analysis trabecular cortical volumetric BMD ( vBMD ) dimension . These data imperative valid assessment effect chronic PPI therapy bone strength . The investigator hypothesize PPI therapy lead decreased cortical trabecular vBMD , cortical dimension bone strength .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>woman 50 75 year old men 40 75 year old Barrett 's esophagus Erosive esophagitis diagnose within past three year , GERD Acid Reflux , take chronic aspirin Starting longterm PPI therapy currently longterm PPI therapy Premenopausal woman men 40 year old</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Barrett 's Esophagus</keyword>
	<keyword>Erosive Esophagitis</keyword>
	<keyword>Proton Pump Inhibitor ( PPI )</keyword>
	<keyword>Bone</keyword>
	<keyword>Bone Density</keyword>
	<keyword>GERD</keyword>
	<keyword>ulcer prophylaxis</keyword>
</DOC>